| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5656501 | HPB | 2017 | 7 Pages |
Abstract
This analysis of a large multi-institution North American experience of DP for treatment of pancreatic adenocarcinoma suggests that short-term postoperative outcomes are improved with MISDP.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Anastasia Plotkin, Eugene P. Ceppa, Ben L. Zarzaur, Elizabeth M. Kilbane, Taylor S. Riall, Henry A. Pitt,